Mechanisms of Arrhythmias and Conduction Disorders in Older Adults

Clinics in Geriatric Medicine

Volumn 28, Issue 4, 2012, Pages 555-573

  Mirza, Mahek ^a   Strunets, Anton ^a   Shen, Win Kuang ^b   Jahangir, Arshad ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Aging; Arrhythmias; Atrial fibrillation; Elderly; Mechanisms; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT;

ABLATION THERAPY; AGING; ARRHYTHMOGENESIS; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COMORBIDITY; DEFIBRILLATOR; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; GERIATRIC CARE; GERIATRIC DISORDER; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MORTALITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PUBLIC HEALTH SERVICE; REVIEW; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; AGING; ARRHYTHMIAS, CARDIAC; COMORBIDITY; FEMALE; HEART; HEART CONDUCTION SYSTEM; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE;

EID: 84867961836     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2012.08.005     Document Type: Review

References (186)

1. Strait J.B., Lakatta E.G. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin 2012, 8:143-164.
2. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
3. Chugh S.S., Jui J., Gunson K., et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004, 44:1268-1275.
4. Piccini J.P., Hammill B.G., Sinner M.F., et al. Incidence and prevalence of atrial fibrillation and associated mortality among medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 2012, 5:85-93.
5. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
6. Jahangir A., Shen W.K. Pacing in elderly patients. Am Heart J 2003, 146:750-753.
7. Jahangir A., Sagar S., Terzic A. Aging and cardioprotection. J Appl Physiol 2007, 103:2120-2128.
8. Jahangir A., Munger T., Packer D., et al. Atrial fibrillation. Cardiac arrhythmia: mechanisms, diagnosis, and management 2001, 457-499. Lippincott Williams & Wilkins, Philadelphia. 2nd edition. P.J. Potrid, P.R. Kowey (Eds.).
9. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e257-e354.
10. Aronow W.S. Heart disease and aging. Med Clin North Am 2006, 90:849-862.
11. Adabag A.S., Luepker R.V., Roger V.L., et al. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol 2010, 7:216-225.
12. Fuster V., Ryden L.E., Cannom D.S., et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 123:e269-e367.
13. Liu X.K., Jahangir A., Shen W.K. Cardiac arrhythmias. Hazzard's geriatric medicine and gerontology 2009, 951-965. McGraw-Hill, New York. 6th edition. J.B. Halter, J.G. Ouslander, M.E. Tinetti (Eds.).
14. Jahangir A., Lee V., Friedman P.A., et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007, 115:3050-3056.
15. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006, 48:e247-e346.
16. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51:e1-e62.
17. Rosenqvist M., Obel I.W. Atrial pacing and the risk for AV block: is there a time for change in attitude?. Pacing Clin Electrophysiol 1989, 12(1 Pt 1):97-101.
18. Lamas G.A., Lee K.L., Sweeney M.O., et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002, 346:1854-1862.
19. Vlietstra R.E., Jahangir A., Shen W.K. Choice of pacemakers in patients aged 75 years and older: ventricular pacing mode vs. dual-chamber pacing mode. Am J Geriatr Cardiol 2005, 14:35-38.
20. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119-125.
21. Mozaffarian D., Furberg C.D., Psaty B.M., et al. Physical activity and incidence of atrial fibrillation in older adults: the Cardiovascular Health Study. Circulation 2008, 118:800-807.
22. Kim M.H., Johnston S.S., Chu B.C., et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011, 4:313-320.
23. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
24. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
25. Wattigney W.A., Mensah G.A., Croft J.B. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol 2002, 155:819-826.
26. Wattigney W.A., Mensah G.A., Croft J.B. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003, 108:711-716.
27. Ozcan C., Jahangir A., Friedman P.A., et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001, 344:1043-1051.
28. Tsang T.S., Petty G.W., Barnes M.E., et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol 2003, 42:93-100.
29. Wu E.Q., Birnbaum H.G., Mareva M., et al. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin 2005, 21:1693-1699.
30. Myerburg R.J., Hendel R.C. Expanding risk-profiling strategies for prediction and prevention of sudden cardiac death. J Am Coll Cardiol 2010, 56:215-217.
31. Fishman G.I., Chugh S.S., Dimarco J.P., et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 2010, 122:2335-2348.
32. Luu M., Stevenson W.G., Stevenson L.W., et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989, 80:1675-1680.
33. Bayés de Luna A., Coumel P., Leclercq J.F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989, 117:151-159.
34. Cobb L.A., Fahrenbruch C.E., Olsufka M., et al. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 2002, 288:3008-3013.
35. Herlitz J., Andersson E., Bang A., et al. Experiences from treatment of out-of-hospital cardiac arrest during 17 years in Göteborg. Eur Heart J 2000, 21:1251-1258.
36. Gillum R.F. Geographic variation in sudden coronary death. Am Heart J 1990, 119:380-389.
37. Nichol G., Thomas E., Callaway C.W., et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008, 300:1423-1431.
38. Kistler P.M., Sanders P., Fynn S.P., et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol 2004, 44:109-116.
39. Preston C.C., Oberlin A.S., Holmuhamedov E.L., et al. Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev 2008, 129:304-312.
40. Roberts-Thomson K.C., Kistler P.M., Sanders P., et al. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm 2009, 6:587-591.
41. Rodriguez R.D., Schocken D.D. Update on sick sinus syndrome, a cardiac disorder of aging. Geriatrics 1990, 45:26-30. 33-6.
42. Dobrzynski H., Boyett M.R., Anderson R.H. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 2007, 115:1921-1932.
43. Jose A.D. Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol 1966, 18:476-478.
44. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993, 73:413-467.
45. Fleg J.L., O'Connor F., Gerstenblith G., et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995, 78:890-900.
46. Dun W., Boyden P.A. Aged atria: electrical remodeling conducive to atrial fibrillation. J Interv Card Electrophysiol 2009, 25:9-18.
47. Lie J.T., Hammond P.I. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988, 63:552-564.
48. Olivetti G., Melissari M., Capasso J.M., et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circulation Res 1991, 68:1560-1568.
49. Tellez J.O., McZewski M., Yanni J., et al. Ageing-dependent remodelling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol 2011, 96:1163-1178.
50. Cheitlin M.D. Cardiovascular physiology-changes with aging. Am J Geriatr Cardiol 2003, 12:9-13.
51. Huang C., Ding W., Li L., et al. Differences in the aging-associated trends of the monophasic action potential duration and effective refractory period of the right and left atria of the rat. Circ J 2006, 70:352-357.
52. Liu X.K., Jahangir A., Terzic A., et al. Age- and sex-related atrial electrophysiologic and structural changes. Am J Cardiol 2004, 94:373-375.
53. Spach M.S., Heidlage J.F., Dolber P.C., et al. Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study. Heart Rhythm 2007, 4:175-185.
54. Koura T., Hara M., Takeuchi S., et al. Anisotropic conduction properties in canine atria analyzed by high-resolution optical mapping: preferential direction of conduction block changes from longitudinal to transverse with increasing age. Circulation 2002, 105:2092-2098.
55. de Bakker J.M., van Rijen H.M. Continuous and discontinuous propagation in heart muscle. J Cardiovasc Electrophysiol 2006, 17:567-573.
56. Hao X., Zhang Y., Zhang X., et al. TGF-beta1-mediated fibrosis and ion channel remodeling are key mechanisms in producing the sinus node dysfunction associated with SCN5A deficiency and aging. Circ Arrhythm Electrophysiol 2011, 4:397-406.
57. Nerbonne J.M., Kass R.S. Physiology and molecular biology of ion channels contributing to ventricular repolarization. Contemporary cardiology: cardiac repolarization: bridging basic and clinical science 2003, 25-62. Humana Press, Totowa (NJ). I. Gussak, C. Antzelevitch (Eds.).
58. Josephson I.R., Guia A., Stern M.D., et al. Alterations in properties of L-type Ca channels in aging rat heart. J Mol Cell Cardiol 2002, 34:297-308.
59. Jahangir A., Holmuhamedov E.L., Cabrera Aguilera C.C., et al. Molecular basis for the increased vulnerability of the aging heart to injury (abstract). Eur Heart J 2006, 27(Suppl 1):5101.
60. Lakatta E.G., Maltsev V.A., Vinogradova T.M. A coupled system of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circulation Res 2010, 106:659-673.
61. Janczewski A.M., Spurgeon H.A., Lakatta E.G. Action potential prolongation in cardiac myocytes of old rats is an adaptation to sustain youthful intracellular Ca2+ regulation. J Mol Cell Cardiol 2002, 34:641-648.
62. Walker K.E., Lakatta E.G., Houser S.R. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res 1993, 27:1968-1977.
63. Jahangir A., Terzic A. KATP channel therapeutics at the bedside. J Mol Cell Cardiol 2005, 39:99-112.
64. Toro L., Marijic J., Nishimaru K., et al. Aging, ion channel expression, and vascular function. Vascul Pharmacol 2002, 38:73-80.
65. Zhou Y.Y., Lakatta E.G., Xiao R.P. Age-associated alterations in calcium current and its modulation in cardiac myocytes. Drugs Aging 1998, 13:159-171.
66. Xiao R.P., Zhu W., Zheng M., et al. Subtype-specific [alpha]1- and [beta]-adrenoceptor signaling in the heart. Trends Pharmacol Sci 2006, 27:330-337.
67. Morita N., Lee J.H., Bapat A., et al. Glycolytic inhibition causes spontaneous ventricular fibrillation in aged hearts. Am J Physiol Heart Circ Physiol 2011, 301:H180-H191.
68. Lompré A.M., Lambert F., Lakatta E.G., et al. Expression of sarcoplasmic reticulum Ca2+-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res 1991, 69:1380-1388.
69. Taffet G.E., Tate C.A. CaATPase content is lower in cardiac sarcoplasmic reticulum isolated from old rats. Am J Physiol 1993, 264:H1609-H1614.
70. Koban M.U., Moorman A.F., Holtz J., et al. Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence. Cardiovasc Res 1998, 37:405-423.
71. Xu A., Narayanan N. Effects of aging on sarcoplasmic reticulum Ca2+-cycling proteins and their phosphorylation in rat myocardium. Am J Physiol 1998, 275:H2087-H2094.
72. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
73. Anyukhovsky E.P., Sosunov E.A., Chandra P., et al. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovasc Res 2005, 66:353-363.
74. Kawamura S., Takahashi M., Ishihara T., et al. Incidence and distribution of isolated atrial amyloid: histologic and immunohistochemical studies of 100 aging hearts. Pathol Int 1995, 45:335-342.
75. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 1999, 283:1488-1493.
76. Loeb L.A., Wallace D.C., Martin G.M. The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc Natl Acad Sci U S A 2005, 102:18769-18770.
77. Fuster V., Ryden L.E., Cannom D.S., et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011, 57:e101-e198.
78. Nattel S., Shiroshita-Takeshita A., Brundel B.J., et al. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis 2005, 48:9-28.
79. Finet J.E., Rosenbaum D.S., Donahue J.K. Information learned from animal models of atrial fibrillation. Cardiol Clin 2009, 27:45-54. viii.
80. Di Lisa F., Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J Mol Cell Cardiol 2009, 46:775-780.
81. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem J 2009, 417:1-13.
82. Seppet E., Eimre M., Peet N., et al. Compartmentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery. Mol Cell Biochem 2005, 270:49-61.
83. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007, 292:C670-C686.
84. Hagen T.M. Oxidative stress, redox imbalance, and the aging process. Antioxid Redox Signal 2003, 5:503-506.
85. Bak M.I., Wei J.Y., Ingwall J.S. Interaction of hypoxia and aging in the heart: analysis of high energy phosphate content. J Mol Cell Cardiol 1998, 30:661-672.
86. Chicco A.J., Sparagna G.C. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 2007, 292:C33-C44.
87. Lesnefsky E.J., Gudz T.I., Migita C.T., et al. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 2001, 385:117-128.
88. Pepe S. Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes. Exp Gerontol 2005, 40:751-758.
89. Lesnefsky E.J., Minkler P., Hoppel C.L. Enhanced modification of cardiolipin during ischemia in the aged heart. J Mol Cell Cardiol 2009, 46:1008-1015.
90. Jahangir A., Ozcan C., Holmuhamedov E.L., et al. Increased calcium vulnerability of senescent cardiac mitochondria: protective role for a mitochondrial potassium channel opener. Mech Ageing Dev 2001, 122:1073-1086.
91. Darbar D., Herron K.J., Ballew J.D., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003, 41:2185-2192.
92. Olson T.M., Alekseev A.E., Liu X.K., et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006, 15:2185-2191.
93. Olson T.M., Alekseev A.E., Moreau C., et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med 2007, 4:110-116.
94. Ellinor P.T., Yoerger D.M., Ruskin J.N., et al. Familial aggregation in lone atrial fibrillation. Hum Genet 2005, 118:179-184.
95. Andalib A., Brugada R., Nattel S. Atrial fibrillation: evidence for genetically determined disease. Curr Opin Cardiol 2008, 23:176-183.
96. Jahangir A., Sattiaraju S., Shen W.K. Senescence and arrhythmogenesis. Electrical disease of the heart: genetics, mechanisms, treatment, and prevention 2008, 247-260. Springer, London. I. Gussak, C. Antzelevitch (Eds.).
97. Kléber A.G., Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 2004, 84:431-488.
98. Mirza M, Shen WK, Jahangir A. Senescence and arrhythmogenesis. In: Gussak I, Antzelevitch C, editors. Electrical disease of the heart: genetics, mechanisms, treatment, and prevention. 2nd edition. London: Springer, in press.
99. Bonnema D.D., Webb C.S., Pennington W.R., et al. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). J Card Fail 2007, 13:530-540.
100. Adamson P.B., Barr R.C., Callans D.J., et al. The perplexing complexity of cardiac arrhythmias: beyond electrical remodeling. Heart Rhythm 2005, 2:650-659.
101. Polyakova V., Miyagawa S., Szalay Z., et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med 2008, 12:189-208.
102. Allessie M. The " second factor": a first step toward diagnosing the substrate of atrial fibrillation?. J Am Coll Cardiol 2009, 53:1192-1193.
103. Kopecky S.L., Gersh B.J., McGoon M.D., et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987, 317:669-674.
104. Osranek M., Bursi F., Bailey K.R., et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J 2005, 26:2556-2561.
105. Nieuwlaat R., Eurlings L.W., Cleland J.G., et al. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2009, 53:1690-1698.
106. Wijffels M.C., Kirchhof C.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995, 92:1954-1968.
107. Nattel S., Maguy A., Le Bouter S., et al. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007, 87:425-456.
108. Ausma J., Coumans W.A., Duimel H., et al. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res 2000, 47:788-796.
109. Ausma J., Dispersyn G.D., Duimel H., et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 2000, 32:355-364.
110. Dispersyn G.D., Ausma J., Thone F., et al. Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: prelude to apoptosis. Cardiovasc Res 1999, 43:947-957.
111. Knackstedt C., Gramley F., Schimpf T., et al. Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. Cardiovasc Pathol 2008, 17:318-324.
112. Corradi D., Callegari S., Maestri R., et al. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med 2008, 5:782-796.
113. Burstein B., Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008, 51:802-809.
114. Xu J., Cui G., Esmailian F., et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004, 109:363-368.
115. Fynn S.P., Garratt C.J. The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation. Eur Heart J 2002, 23:1487-1489.
116. Everett T.H., Li H., Mangrum J.M., et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000, 102:1454-1460.
117. Lin C.S., Pan C.H. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci 2008, 65:1489-1508.
118. Lin P.H., Lee S.H., Su C.P., et al. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 2003, 35:1310-1318.
119. Myerburg R.J. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001, 12:369-381.
120. Geelen P., Lorga Filho A., Primo J., et al. Experience with implantable cardioverter defibrillator therapy in elderly patients. Eur Heart J 1997, 18:1339-1342.
121. Panotopoulos M., Panagiotis T., Axtell K., et al. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 1997, 29:556-560.
122. Saksena S., Mathew P., Giorgberidze I., et al. Implantable defibrillator therapy for the elderly. Am J Geriatr Cardiol 1998, 7:11-13.
123. Wilkoff B.L., Cook J.R., Epstein A.E., et al. Dual-chamber pacing-or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002, 288:3115-3123.
124. Penn J., Goldenberg I., Moss A.J., et al. Improved outcome with preventive cardiac resynchronization therapy in the elderly: a MADIT-CRT substudy. J Cardiovasc Electrophysiol 2011, 22:892-897.
125. Myerburg R.J., Castellanos A. Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 2006, 3:235-239.
126. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
127. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
128. van Rees J.B., Borleffs C.J., Thijssen J., et al. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace 2012, 14:66-73.
129. Jahangir A., Shen W.K., Neubauer S.A., et al. Relation between mode of pacing and long-term survival in the very elderly. J Am Coll Cardiol 1999, 33:1208-1216.
130. Krahn A.D., Connolly S.J., Roberts R.S., et al. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J 2004, 147:837-840.
131. Grimm W. Outcomes of elderly heart failure recipients of ICD and CRT. Int J Cardiol 2008, 125:154-160.
132. Kocovic D.Z. Cardiac resynchronization therapy and other new approaches for the treatment of heart failure in the elderly. Am J Geriatr Cardiol 2006, 15:108-113.
133. Foley P.W., Chalil S., Khadjooi K., et al. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population. Europace 2008, 10:1302-1307.
134. Silva R.M., Mont L., Nava S., et al. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004, 27:971-975.
135. Scheinman M.M. NASPE survey on catheter ablation. Pacing Clin Electrophysiol 1995, 18:1474-1478.
136. Tchou P., Jazayeri M., Denker S., et al. Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation 1988, 78:246-257.
137. Stevenson W.G., Khan H., Sager P., et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993, 88:1647-1670.
138. Gurevitz O.T., Glikson M., Asirvatham S., et al. Use of advanced mapping systems to guide ablation in complex cases: experience with noncontact mapping and electroanatomic mapping systems. Pacing Clin Electrophysiol 2005, 28:316-323.
139. Joshi S., Wilber D.J. Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives. J Cardiovasc Electrophysiol 2005, 16:S52-S58.
140. Pedrinazzi C., Durin O., Agricola P., et al. Efficacy and safety of radiofrequency catheter ablation in the elderly. J Interv Card Electrophysiol 2007, 19:179-185.
141. Inada K., Roberts-Thomson K.C., Seiler J., et al. Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease. Heart Rhythm 2010, 7:740-744.
142. Kelly P., Ruskin J.N., Vlahakes G.J., et al. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 1990, 15:267-273.
143. Brugada J., Aguinaga L., Mont L., et al. Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol 2001, 37:529-533.
144. Fleg J.L., Kennedy H.L. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982, 81:302-307.
145. Kennedy H.L., Whitlock J.A., Sprague M.K., et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985, 312:193-197.
146. Hinkle L.E., Carver S.T., Stevens M. The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. Am J Cardiol 1969, 24:629-650.
147. Kannel W.B., Cupples L.A., D'Agostino R.B. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J 1987, 113:799-804.
148. Jouven X., Zureik M., Desnos M., et al. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000, 343:826-833.
149. Frolkis J.P., Pothier C.E., Blackstone E.H., et al. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003, 348:781-790.
150. Messerli F.H., Ventura H.O., Elizardi D.J., et al. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984, 77:18-22.
151. Bigger J.T., Fleiss J.L., Kleiger R., et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984, 69:250-258.
152. Huikuri H.V., Mäkikallio T.H., Raatikainen M.J., et al. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 2003, 108:110-115.
153. Stevenson W.G., Stevenson L.W., Middlekauff H.R., et al. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993, 88:2953-2961.
154. Aronow W.S., Ahn C., Mercando A.D., et al. Prevalence and association of ventricular tachycardia and complex ventricular arrhythmias with new coronary events in older men and women with and without cardiovascular disease. J Gerontol A Biol Sci Med Sci 2002, 57:M178-M180.
155. Volpi A., Cavalli A., Turato R., et al. Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3) Data Base. Am Heart J 2001, 142:87-92.
156. Trusty J.M., Beinborn D.S., Jahangir A. Dysrhythmias and the athlete. AACN Clin Issues 2004, 15:432-448.
157. Ornato J.P., Peberdy M.A., Tadler S.C., et al. Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the second national registry of myocardial infarction in the US. Resuscitation 2001, 48:117-123.
158. Behar S., Goldbourt U., Reicher-Reiss H., et al. Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Am J Cardiol 1990, 66:1208-1211.
159. Huikuri H.V., Castellanos A., Myerburg R.J. Medical progress: sudden death due to cardiac arrhythmias. N Engl J Med 2001, 345:1473-1482.
160. Schouten E.G., Dekker J.M., Meppelink P., et al. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991, 84:1516-1523.
161. Steinberg J.S., Berbari E.J. The signal-averaged electrocardiogram: update on clinical applications. J Cardiovasc Electrophysiol 1996, 7:972-988.
162. Cook J.R., Flack J.E., Gregory C.A., et al. Influence of the preoperative signal-averaged electrocardiogram on left ventricular function after coronary artery bypass graft surgery in patients with left ventricular dysfunction. The CABG Patch Trial. Am J Cardiol 1998, 82:285-289.
163. Podrid P.J., Graboys T.B. Exercise stress testing in the management of cardiac rhythm disorders. Med Clin North Am 1984, 68:1139-1152.
164. Couderc J.P., Zareba W., McNitt S., et al. Repolarization variability in the risk stratification of MADIT II patients. Europace 2007, 9:717-723.
165. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006, 47:456-463.
166. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 2006, 47:1820-1827.
167. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003, 42:954-970.
168. Klocke F.J., Baird M.G., Lorell B.H., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003, 42:1318-1333.
169. Azaouagh A., Churzidse S., Konorza T., et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clin Res Cardiol 2011, 100:383-394.
170. Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010, 121:1533-1541.
171. Wilber D.J., Garan H., Finkelstein D., et al. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988, 318:19-24.
172. Chen L.Y., Jahangir A., Decker W.W., et al. Score indices for predicting electrophysiologic outcomes in patients with unexplained syncope. J Interv Card Electrophysiol 2005, 14:99-105.
173. Bachinsky W.B., Linzer M., Weld L., et al. Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol 1992, 69:1044-1049.
174. Priori S.G., Schwartz P.J., Napolitano C., et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003, 348:1866-1874.
175. Moya A., Sutton R., Ammirati F., et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009, 30:2631-2671.
176. Priori S.G., Napolitano C., Gasparini M., et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002, 105:1342-1347.
177. Brugada J., Brugada R., Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003, 108:3092-3096.
178. Nienaber C.A., Hiller S., Spielmann R.P., et al. Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol 1990, 15:948-955.
179. Buxton A.E., Lee K.L., Hafley G.E., et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002, 106:2466-2472.
180. Calkins H., Kuck K.H., Cappato R., et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol 2012, 33:171-257.
181. Patel M.R., Bailey S.R., Bonow R.O., et al. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012, 59:1995-2027.
182. Skanes A.C., Healey J.S., Cairns J.A., et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol 2012, 28:125-136.
183. Camm A.J., Kirchhof P., Lip G.Y., et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010, 12:1360-1420.
184. Dubner S., Auricchio A., Steinberg J.S., et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 2012, 14:278-293.
185. Curtis A.B. Update on the clinical management of atrial fibrillation: guidelines and beyond. Postgrad Med 2011, 123:7-20.
186. Savelieva I., Kakouros N., Kourliouros A., et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace 2011, 13:308-328.